Biomerica, Inc. (NASDAQ:BMRA – Get Free Report)’s share price crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.36 and traded as high as $0.56. Biomerica shares last traded at $0.51, with a volume of 1,455,581 shares.
Biomerica Price Performance
The business has a 50 day moving average of $0.40 and a 200 day moving average of $0.36. The firm has a market capitalization of $9.28 million, a price-to-earnings ratio of -1.49 and a beta of -0.98.
Biomerica (NASDAQ:BMRA – Get Free Report) last announced its quarterly earnings data on Tuesday, January 14th. The company reported ($0.06) EPS for the quarter. Biomerica had a negative return on equity of 90.19% and a negative net margin of 100.52%.
About Biomerica
Biomerica, Inc, a biomedical technology company, develops, patents, manufactures, and markets diagnostic and therapeutic products for the detection and/or treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications; or to measure bacteria, hormones, antibodies, antigens, or other substances which may exist in the human body, stools, or blood in extremely small concentrations.
See Also
- Five stocks we like better than Biomerica
- What is a SEC Filing?
- 3 Must-Have ETFs Set to Dominate This Quarter
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Seeking Stability? These 3 Stocks Offer Strong Potential
- Best Stocks Under $5.00
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Receive News & Ratings for Biomerica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biomerica and related companies with MarketBeat.com's FREE daily email newsletter.
